<?xml version="1.0" encoding="UTF-8"?>
<p>Another vaccine that has entered clinical trials in China has been developed by CanSino Biologics (Tianjin, China), the company that also has developed a vaccine for Ebola. Also based on the S protein, the vaccine (Ad5-nCoV) is based on their adenovirus vaccine platform, and is undergoing phase I clinical trials in healthy individuals between 18â€“60 years of age in Wuhan, China- (ClinicalTrials.gov: NCT04313127) [
 <xref rid="B60-viruses-12-00526" ref-type="bibr">60</xref>].
</p>
